Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 49 studies | 46% ± 22% | |
pericyte | 24 studies | 43% ± 20% | |
fibroblast | 22 studies | 38% ± 20% | |
macrophage | 21 studies | 42% ± 23% | |
endothelial cell of lymphatic vessel | 20 studies | 50% ± 23% | |
smooth muscle cell | 17 studies | 37% ± 16% | |
astrocyte | 17 studies | 54% ± 19% | |
oligodendrocyte precursor cell | 16 studies | 66% ± 21% | |
conventional dendritic cell | 15 studies | 26% ± 10% | |
vein endothelial cell | 14 studies | 38% ± 24% | |
microglial cell | 14 studies | 41% ± 17% | |
oligodendrocyte | 13 studies | 36% ± 14% | |
capillary endothelial cell | 12 studies | 35% ± 14% | |
endothelial cell of artery | 12 studies | 31% ± 15% | |
glutamatergic neuron | 12 studies | 60% ± 24% | |
endothelial cell of vascular tree | 12 studies | 36% ± 23% | |
dendritic cell | 11 studies | 43% ± 16% | |
classical monocyte | 11 studies | 27% ± 11% | |
GABAergic neuron | 11 studies | 55% ± 21% | |
myeloid cell | 10 studies | 47% ± 19% | |
adipocyte | 9 studies | 35% ± 13% | |
non-classical monocyte | 8 studies | 27% ± 12% | |
epithelial cell | 8 studies | 36% ± 19% | |
monocyte | 7 studies | 52% ± 21% | |
interneuron | 7 studies | 56% ± 23% | |
mast cell | 7 studies | 25% ± 12% | |
neuron | 6 studies | 53% ± 23% | |
retinal ganglion cell | 6 studies | 48% ± 18% | |
retina horizontal cell | 6 studies | 45% ± 21% | |
amacrine cell | 5 studies | 40% ± 16% | |
cardiac muscle cell | 5 studies | 53% ± 14% | |
lymphocyte | 5 studies | 31% ± 11% | |
myofibroblast cell | 5 studies | 32% ± 16% | |
T cell | 5 studies | 26% ± 6% | |
basal cell | 5 studies | 34% ± 17% | |
connective tissue cell | 5 studies | 27% ± 13% | |
cholangiocyte | 4 studies | 39% ± 23% | |
CD4-positive, alpha-beta T cell | 4 studies | 23% ± 4% | |
granule cell | 4 studies | 23% ± 6% | |
B cell | 4 studies | 25% ± 7% | |
mesothelial cell | 4 studies | 34% ± 13% | |
mononuclear phagocyte | 4 studies | 37% ± 18% | |
alveolar macrophage | 4 studies | 58% ± 20% | |
type B pancreatic cell | 3 studies | 43% ± 19% | |
endothelial cell of sinusoid | 3 studies | 50% ± 7% | |
hepatic stellate cell | 3 studies | 61% ± 16% | |
glomerular endothelial cell | 3 studies | 29% ± 2% | |
GABAergic interneuron | 3 studies | 53% ± 2% | |
glial cell | 3 studies | 28% ± 12% | |
progenitor cell | 3 studies | 33% ± 9% | |
plasma cell | 3 studies | 24% ± 6% | |
endocardial cell | 3 studies | 55% ± 22% | |
ciliated cell | 3 studies | 19% ± 5% | |
GABAergic amacrine cell | 3 studies | 42% ± 12% | |
OFF-bipolar cell | 3 studies | 28% ± 6% | |
glycinergic amacrine cell | 3 studies | 47% ± 14% | |
hepatocyte | 3 studies | 44% ± 32% | |
retinal pigment epithelial cell | 3 studies | 39% ± 19% | |
abnormal cell | 3 studies | 38% ± 24% | |
ependymal cell | 3 studies | 61% ± 11% | |
neutrophil | 3 studies | 33% ± 15% | |
leukocyte | 3 studies | 33% ± 10% | |
erythrocyte | 3 studies | 57% ± 17% | |
natural killer cell | 3 studies | 24% ± 7% | |
muscle cell | 3 studies | 36% ± 15% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 3674.58 | 1442 / 1445 | 100% | 30.34 | 183 / 183 |
skin | 100% | 7023.82 | 1808 / 1809 | 99% | 56.87 | 468 / 472 |
ovary | 100% | 4270.32 | 180 / 180 | 99% | 25.95 | 426 / 430 |
breast | 100% | 6029.22 | 459 / 459 | 99% | 29.31 | 1105 / 1118 |
lung | 100% | 7518.31 | 578 / 578 | 99% | 25.52 | 1138 / 1155 |
brain | 98% | 2505.88 | 2578 / 2642 | 100% | 39.81 | 703 / 705 |
adrenal gland | 100% | 5063.00 | 258 / 258 | 97% | 31.88 | 222 / 230 |
thymus | 100% | 4432.96 | 653 / 653 | 96% | 16.99 | 582 / 605 |
uterus | 100% | 4809.64 | 170 / 170 | 96% | 22.58 | 440 / 459 |
bladder | 100% | 3802.76 | 21 / 21 | 93% | 18.73 | 467 / 504 |
stomach | 94% | 2087.48 | 339 / 359 | 97% | 21.54 | 278 / 286 |
intestine | 99% | 2947.58 | 960 / 966 | 92% | 16.44 | 484 / 527 |
kidney | 99% | 2308.65 | 88 / 89 | 89% | 21.36 | 801 / 901 |
prostate | 99% | 3365.31 | 243 / 245 | 82% | 9.39 | 410 / 502 |
pancreas | 68% | 887.91 | 224 / 328 | 98% | 21.45 | 174 / 178 |
liver | 59% | 873.99 | 133 / 226 | 66% | 10.29 | 267 / 406 |
adipose | 100% | 7618.51 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 4085.86 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 7371.95 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 19.17 | 1 / 1 |
peripheral blood | 99% | 5417.36 | 923 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 45.46 | 79 / 80 |
heart | 99% | 3789.89 | 850 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 22.44 | 44 / 45 |
lymph node | 0% | 0 | 0 / 0 | 97% | 21.95 | 28 / 29 |
muscle | 95% | 1758.30 | 765 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0060271 | Biological process | cilium assembly |
GO_0061512 | Biological process | protein localization to cilium |
GO_1903527 | Biological process | positive regulation of membrane tubulation |
GO_0061000 | Biological process | negative regulation of dendritic spine development |
GO_0045724 | Biological process | positive regulation of cilium assembly |
GO_0043001 | Biological process | Golgi to plasma membrane protein transport |
GO_0099175 | Biological process | regulation of postsynapse organization |
GO_0098978 | Cellular component | glutamatergic synapse |
GO_0043197 | Cellular component | dendritic spine |
GO_0002102 | Cellular component | podosome |
GO_0032588 | Cellular component | trans-Golgi network membrane |
GO_0000139 | Cellular component | Golgi membrane |
GO_0005829 | Cellular component | cytosol |
GO_0005547 | Molecular function | phosphatidylinositol-3,4,5-trisphosphate binding |
GO_0045296 | Molecular function | cadherin binding |
GO_0005546 | Molecular function | phosphatidylinositol-4,5-bisphosphate binding |
GO_0001786 | Molecular function | phosphatidylserine binding |
GO_0005096 | Molecular function | GTPase activator activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0005515 | Molecular function | protein binding |
Gene name | ASAP1 |
Protein name | Alternative protein ASAP1 ASAP1 protein ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1 (130 kDa phosphatidylinositol 4,5-bisphosphate-dependent ARF1 GTPase-activating protein) (ADP-ribosylation factor-directed GTPase-activating protein 1) (ARF GTPase-activating protein 1) (Development and differentiation-enhancing factor 1) (DEF-1) (Differentiation-enhancing factor 1) (PIP2-dependent ARF1 GAP) ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 (Development and differentiation enhancing factor 1, isoform CRA_b) |
Synonyms | DDEF1 PAG2 hCG_2009092 KIAA1249 |
Description | FUNCTION: Possesses phosphatidylinositol 4,5-bisphosphate-dependent GTPase-activating protein activity for ARF1 (ADP ribosylation factor 1) and ARF5 and a lesser activity towards ARF6. May coordinate membrane trafficking with cell growth or actin cytoskeleton remodeling by binding to both SRC and PIP2. May function as a signal transduction protein involved in the differentiation of fibroblasts into adipocytes and possibly other cell types. Part of the ciliary targeting complex containing Rab11, ASAP1, Rabin8/RAB3IP, RAB11FIP3 and ARF4, which direct preciliary vesicle trafficking to mother centriole and ciliogenesis initiation . . |
Accessions | ENST00000524124.5 H0YBM4 A0A0A0MRE5 ENST00000520342.5 L8E8W2 E5RFD9 ENST00000521075.5 E5RHA9 ENST00000520927.5 ENST00000521426.5 ENST00000357668.2 ENST00000518721.6 [Q9ULH1-1] ENST00000524299.1 E5RHD7 Q8WWA4 Q9ULH1 H0YBF7 ENST00000519483.5 |